Tracking the Evolution of Non–Small-Cell Lung Cancer
Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan et al. · New England Journal of Medicine · 2017
BACKGROUND: Among patients with non-small-cell lung cancer (NSCLC), data on intratumor heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. We wanted to prospectively investigate intratumor heterogeneity in relation to clinical outcome and to determine the clonal nature of driver events and evolutionary processes in early-stage NSCLC. METHODS: In this prospective cohort study, we performed multiregion whole-exome sequencing on 100 early-stage NSCLC tumors that had been resected before systemic therapy. We sequenced and analyzed 327 tumor regions to define evolutionary histories, obtain a census of clonal and subclonal events, and assess the relationship between intratumor heterogeneity and recurrence-free survival. RESULTS: ), which remained significant in multivariate analysis. CONCLUSIONS: Intratumor heterogeneity mediated through chromosome instability was associated with an increased risk of recurrence or death, a finding that supports the potential value of chromosome instability as a prognostic predictor. (Funded by Cancer Research UK and others; TRACERx ClinicalTrials.gov number, NCT01888601 .).
Cited by 2,337 works. doi:10.1056/nejmoa1616288 Open-access PDF
Authors
- Mariam Jamal‐Hanjani
- Gareth A. Wilson
- Nicholas McGranahan
- Nicolai J. Birkbak
- Thomas B.K. Watkins
- Selvaraju Veeriah
- Seema Shafi
- Diana Johnson
- Richard Mitter
- Rachel Rosenthal
- Max Salm
- Stuart D. Horswell
- Mickael Escudero
- Nik Matthews
- Andrew Rowan
- David Allan Moore
- Samra Turajlic
- Hang Xu
- Siow Ming Lee
References
- Global cancer statistics
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- Cancer statistics, 2013
- Signatures of mutational processes in human cancer
- Comprehensive molecular profiling of lung adenocarcinoma
- Comprehensive genomic characterization of squamous cell lung cancers
- Discovery and saturation analysis of cancer genes across 21 tumour types
- Absolute quantification of somatic DNA alterations in human cancer
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing